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Abstract
PURPOSE: The purpose of this research study was to evaluate the use of the CRAFFT
tool within a pediatric primary care setting. The specific objective was to assess the frequency of
documentation of substance use screening, counseling, and/or intervention before and after the
implementation of the CRAFFT tool.
METHOD: The practice site chose to implement an evidence based adolescent substance
use screening tool (CRAFFT Tool) to improve practice. This practice improvement project
utilized a descriptive design with a review of electronic medical records before and after a
substance use screening tool was implemented. Two hundred medical records were reviewed,
100 in the pre-phase of the study and 100 in the post-phase of the study. The electronic medical
record was reviewed to assess frequency of adolescent substance use documentation before and
after the tool was introduced.
RESULTS: Prior to implementation of the CRAFFT tool, substance use screening rates
were 10% and documented as “no risk factors” in the narrative note. After the CRAFFT
implementation, screening rates were 31%. Documentation included the use of the CRAFFT
tool (10%, n=10) and as no “risk factors” for substance use and 20% (n=19). The mean
CRAFFT score was 0. Chi square analysis revealed a statistically significant difference
(p<0.001) between using the craft tool and the documentation of substance use screening.
CONCLUSION: Overall, screening improved after the clinic implemented the CRAFFT
tool, but standardized documentation continues to be a problem. Additional research and
suggested practice implications may aid in the continued improvement of adolescent substance
use screening.
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Introduction
Substance abuse disorder is defined as the recurrent use of alcohol or any other drugs that
cause clinical impairment, health problems, or failure to meet responsibility at work or school
(Center for Behavioral Health Statistics and Quality, 2015). In the United States, 1.3 million
adolescents 12 to 17 were diagnosed with substance abuse disorder, which is one out of every 20
adolescents (Center for Behavioral Health Statistics and Quality, 2015). Substance abuse in the
adolescent population can lead to risky behaviors, such as unprotected sex, driving under the
influence or riding with someone under the influence of drugs/alcohol, and committing a crime
(Substance Abuse and Mental Health Services Administration, 2015). Adolescent substance
abuse can also cause changes in brain development, increased risk for memory problems and it
also increases the risk of suicide (Substance Abuse and Mental Health Services Administration,
2015). If these trends continue there is a high likelihood that an increased number of individuals
with addiction, multiple co-morbidities and substance abuse related death will be encountered as
adults in the healthcare system. The purpose of this research study was to evaluate a method to
improve adolescent substance abuse screening within a pediatric setting.
Background
Twenty-seven million Americans age 12 and older were current drug users in 2014; of
the 27 million, 2.3 million were adolescents 12 to 17, which equates to 9.4 percent of the United
States adolescent population (Center for Behavioral Health Statistics and Quality, 2015).
According to the 2014 National Survey on Drug Use and Health, 139.7 million people aged 12
and older were current users of alcohol, adolescents aged 12 to 20 account for 8.7 million of
those. According to the survey 667,000 adolescents 12 to 17 were current users of marijuana,
169,000 were current users of stimulants (methamphetamine), 136,000 were current users of
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hallucinogens (LSD, PCP, peyote, mescaline, mushrooms, ecstasy), 39,000 were current users of
cocaine, and 28,000 were current users of heroin (Center for Behavioral Health Statistics and
Quality, 2015).
Healthcare and societal costs are also of concern. Substance abuse costs the United States
as a whole $740 billion dollars annually: $168 billion related to tobacco, $27 billion related to
alcohol, $11 billion related to illicit drugs, and $26 billion related to miss used prescription drugs
(NIH, 2018). Every one dollar spent on substance abuse treatment yields a return of $4 to $7 by
having a reduction in crime, reduction in criminal justice costs, and theft (NIH, 2018).
Specifically, for healthcare costs, every one dollar spent on substance abuse treatment will yield
a return of $12 dollars in healthcare cost savings (NIH, 2018). Kentucky ranks seventh highest
in the nation for drug overdose deaths among those who are 12 to 25 years old, and third highest
in the nation for smoking among high school students (Cole, Logan, & Scrivner, 2017). A study
of 1,968 adolescents who were in treatment for substance abuse reported that 62% were
consuming alcohol with the average age of drinking beginning at 13.1 years (Cole, Logan, &
Scrivner, 2017). Within the same study 88% reported illegal drug use, the average age of first
using drugs was 12.9 years (Cole, Logan, & Scrivner, 2017). The most commonly used drugs
among the adolescents were: 86% marijuana, 22% opioids, 20% synthetic drugs, 19% CNS
depressants, 18% stimulants/cocaine, and 16% hallucinogens and inhalants (Cole, Logan, &
Scrivner, 2017).
Adolescent substance abuse is a nationally recognized concern and involvement of
primary care providers is needed (Centers for Disease Control and Prevention, 2015). The
American Academy of Pediatrics, American Medical Association Guidelines for Adolescent
Preventive Services, and the American Academy of Pediatrics Bright Futures guidelines all
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recommend that providers should screen adolescents routinely, or at a minimum once a year, for
alcohol and substance use, and provide office interventions or referrals when needed (American
Academy of Pediatrics, 2005; Hagan JF, Shaw JS, Duncan PM, eds. 2017.; American Medical
Association, 1994; Committee on Substance Abuse, 2010).
One way to address adolescent substance abuse screening is using the CRAFFT tool in
family practice and pediatric offices. CRAFFT is an acronym based on the major categories of
questions on the screening tool: C-car, R-relax, A-alone, F-forget, F-friends, and T-trouble (The
Center for Adolescent Substance Abuse Research, 2016). The CRAFFT screening tool was
tested for reliability and when used with appropriate motivational interviewing is highly reliable
(Committee on Substance Abuse, 2010). In a primary care setting the CRAFFT screening tool
was shown to identify more adolescents for substance abuse than other screening tools
(D'Amico, et al., 2016). The CRAFFT screening tool is an effective option to identify adolescent
substance abuse due to its short questions and the brief time it takes to complete, low expense,
flexibility to be used either as a paper form or electronic form, and it is an evidence-based
practice tool. Implementing the CRAFFT screening tool in the primary care setting can increase
identification of those adolescents in need of further interventions. Without adequate
identification of those in need, it is impossible to provide counseling and/or treatment.
The objective for this study was to assess the frequency of documentation of substance
use screening, counseling, and/or intervention in a pediatric clinic before and after the
implementation of the CRAFFT tool.
Nursing Theory
Ida Jean Orlando’s Nursing Process was chosen because the aspects of communication
between the nurse and the patient relationship are most important. Orlando’s Nursing Process
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Discipline Theory focuses on the interaction between the nurse and the patient. The main
concepts of Orlando’s theory are: function of professional nursing, presenting behavior,
immediate reaction, nursing process discipline and improvement (Nursing Theory, 2015). Below
is a description of each concept.
•

Function of professional is the main concept behind this theory, nurse to identify
the patients immediate need for help. Nurses responds to individuals who need
help and assist in any means possible to supply the help that is needed (Nursing
Theory, 2015).

•

Presenting behavior is defined as the patient’s problem. The presenting problem
is what initiates the nurse’s response to help. A presenting behavior can be a
direct spoken need for help, or a subdued behavior; it is the nurse’s role to
identify through perception the patient’s need for help. The presenting behavior
creates an internal response in the nurse, which then creates a response in the
patient (Nursing Theory, 2015).

•

Immediate reaction is the internal response of both the nurse and the patient. The
internal reaction is composed of the automatic response of the senses. This
response causes a reaction from the patient and the nurse to develop a nursepatient relationship (Nursing Theory, 2015).

•

Nursing process discipline is researching the patient’s needs. Using the nursepatient relationship the nurse assesses the needs of the patient and initiates a
reaction or response to those needs. The nurses’ response to the needs of the
patient is what creates the patient’s behavior to identify if the help the nurse is
offering is useful. In the event the nurse does not explore the patients identified
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need for help, it could damage the nurse-patient relationship, resulting in the
patient becoming silent (Nursing Theory, 2015).
•

Improvement is the overall resolution of the patient’s needs. This is measured by
completing communication circle of the nurse-patient relationship. The patient
seeks help, the nurse identifies the need for help, and the nurse helps the patient
with a resolution (Nursing Theory, 2015).

Orlando’s Nursing Process Discipline Theory involves building a relationship through
open communication with the patient and identifying the overall needs of a patient (Nursing
Theory, 2015
Implementing this theory into practice may help improve communication between the
nurse practitioner and the patient which may result in increased trust during visits. An increase
in trust may allow the patient to feel more comfortable to discuss sensitive health topics, such as
substance abuse, pertaining to themselves or others. This theory also encourages the nurse/nurse
practitioner to read the patient’s non-verbal reactions to questions while completing an
assessment. During an assessment identifying non-verbal cues may be more important than
verbal communication, especially in the adolescent population. Adolescents often times are
scared to divulge information for fear of getting in trouble or a parent may be in the room which
could lead to untruthful answers. Combining the main concepts of this theory within practice
validates the importance of creating the open relationship between the nurse/nurse practitioner to
encourage truthful answering of screening questionnaires such as the CRAFFT Tool.
Purpose
The purpose of this research study was to evaluate a method to improve adolescent
substance abuse screening within a primary care setting. The objective for this study was to
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assess the frequency of documentation of substance use screening, counseling, and/or
intervention in a pediatric clinic before and after the implementation of the CRAFFT tool.
Methods
Design
This practice improvement project utilized a descriptive design with a review of
electronic medical records before and after a substance use screening tool was implemented.
The practice site chose to implement an evidence based adolescent substance use screening tool
(CRAFFT Tool) to improve practice. This study evaluated the implementation of the tool. The
electronic medical record was reviewed to assess frequency of adolescent substance use
documentation before and after the tool was introduced.
Sample and Settings
This study took place at a pediatric practice which had a combined total of 8 nurse
practitioners and physicians. The population of interest was adolescents aged 12-17 who were
seen at the pediatric practice. A total of two hundred medical charts of adolescents aged 12-17
were randomly selected and reviewed for the study; 100 charts were reviewed from 2017 before
the screening tool was implemented and 100 charts were reviewed from 2018, after the screening
tool was implemented.
Inclusion criteria included: a) adolescents between 12-17 years old who were seen at the
practice site between June 1, 2017 to August 31, 2017, and June 1st to August 31st, 2018, b) for
a sports physical, annual exam or non-emergent visit. Exclusion criteria: a) children under 12
years of age or over 17 years of age b) children seen for a sick visit, an injury or an emergent
condition.

7

Adolescent Substance Use Screening
Measures
The following data was extracted from the medical records by the PI: gender (male,
female, other), age (in years), and race (African American/Black, Caucasian/white, Hispanic,
Black Hispanic, White Hispanic, Asian, and/or other), and history of smoking, drug use, alcohol
use, any documentation of substance use screening and counseling. For the 2018 chart review,
the PI also extracted the CRAFFT score, as well as reviewed the narrative to identify if providers
were documenting the score.
The CRAFFT tool is a one-page screening tool that was utilized in the form of a written
document. The CRAFFT tool was developed by Dr. Knight and colleagues at the Center for
Adolescent Substance Abuse Research (CeASAR) at Boston Children’s Hospital (The Center for
Adolescent Substance Abuse Research, 2016). CRAFFT is an acronym based on the major
categories of questions on the screening tool: C-car, R-relax, A-alone, F-forget, F-friends, and Ttrouble. The CRAFFT contains two parts (A and B) and is comprised of nine yes or no
questions. Part A is three questions that every adolescent is to answer, and Part B is comprised of
six questions. Question one in Part B is answered by all adolescents and the remaining five
questions are answered by only those who answered yes to any of the questions in Part A or
question one of Part B. The CRAFFT screening tool was tested for reliability and when used
with appropriate motivational interviewing is highly reliable. (Committee on Substance Abuse,
2010).
Procedures
While participating in a clinical experience at one of the pediatric offices in a large
healthcare system the PI became aware of provider interest in screening adolescents for
substance abuse. After further discussion and investigation into appropriate screening tools, a
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collaboration between the author and the providers lead to the selection of the CRAFFT tool. A
year end implementation date was set. Approval was granted by the office manager at the
pediatric office to conduct the education of the CRAFFT tool and the importance of adolescent
substance use screening.
The PI created education packets for the medical assistants (MA) and providers. The MA
packet included a cover letter explaining the studies purpose, PI contact information, and a
sample of the CRAFFT Tool and scoring form. A project poster was placed in the breakroom
throughout the duration of the study. The provider packet included a letter explaining the study’s
purpose, PI contact information, a sample of the CRAFFT Tool and scoring form, an example of
a conversation with an adolescent about substance abuse, and a list of area substance abuse
treatment centers.
A pre and post chart review was conducted. Chart reviews were completed from two
different time periods. The first-time period was June 1, 2017 through August 31, 2017. The
second chart review was June 1st, 2018 through August 31, 2018. These time periods were
chosen to evaluate substance use screening and documentation prior to the CRAFFT tool being
implemented and after the tool was implemented. Additionally, these time frames were chosen
as a majority of sports exams and annual well exams for this population occur during the summer
when the adolescents are not in school. Annual visits are generally scheduled for longer time
periods as they involve a detailed history and administration of other screening tools. The
summer months provided an ample number of patients for the office to acclimate to the tool.
The PI requested 200 randomly selected medical record numbers of adolescents aged 1217 who were seen at the pediatric practice during the study dates from the healthcare system’s
Clinical Information Analysis, Decision Support, Information Technology and Clinical
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Effectiveness departments. Medical record numbers were requested from two time periods for
comparison: 100 randomly selected medical record numbers of adolescents that were seen
between June 1st and August 31st, 2017 and another 100 medical record numbers for adolescents
seen between June 1st, 2018 and August 31, 2018.
Two electronic cross walks were created to de-identify the medical record numbers, one
for 2017 and one for 2018. Each Medical record correlated to a study number (1-100). The
cross walk was be kept in a separate password protected and firewall protected file on the
password protected H drive through the healthcare institution. The cross walk was destroyed
when the data collection was completed. All data collected from the chart review was stored on
a secure password protected, firewall protected H drive through the healthcare institution.
Statistics
Statistical data was analyzed using SPSS 24.0. Descriptive statistics such as standard
deviation, means, and percentages were used to evaluate demographic data: age, gender, and
race. The Chi-Square test and Fisher Exact test were used to determine if an association occurred
between variables such as implementing the CRAFFT Tool and substance use screening, as well
as documentation of substance use history and substance use screening.
Results
Pre-Screening
The sample included a total of 100 medical records, and of those 96 were deemed eligible
per inclusion/exclusion criteria. Demographic analysis revealed 41.7% female, 92.7% Caucasian
(See Table 1). The mean age was 15 years. Substance use screening was documented in 10% of
the records and was documented as no “risk factors” for substance use. In the narrative section
of the provider note, substance use counseling was documented in an additional 10% of the
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records as the patient was given an anticipatory guidance handout from the provider. Of the 10%
with anticipatory guidance documented it was identified that one patient record had
documentation of substance use screening and had documented anticipatory guidance. The
remaining nine had either documentation of substance use screening or anticipatory guidance
documented, but not both (See Table 4).
Substance use history was reviewed during the pre-screening phase of the study by
reviewing the documentation of tobacco use, alcohol use, and drug use. Although the results in
each phase of the study were not statistically significant when compared to substance use
screening, it was clinically significant as this should have a documentation rate of 100%.
Documenting patient’s substance use history allows for a thorough assessment. In the prescreening phase of the study history of abuse was documented as followed: smoking-86.5%,
alcohol-69.8%, and drug use-70.8% of the time (See Table 3).
Post-Screening
The sample included a total of 100 medical record reviews, however only 96 were
eligible due to inclusion/exclusion criteria. Demographic analysis included 60.4% female, race
92.7% Caucasian (See Table 1). The mean age within the post-screening phase was 14.
Substance use screening was found to be documented in 31% (n=30) of the medical records, it
was documented 21% (n=20) as no “risk factors” for substance use and 10% (n=10) the
CRAFFT tool was used. The mean CRAFFT score documented was 0. In the narrative section of
the provider note, substance use counseling was documented in an additional (n=16) records as
the patient was given an anticipatory guidance handout from the provider. Nine patient records
had documentation of substance use screening and documented anticipatory guidance. The
remaining seven records had either a substance use screening or anticipatory guidance
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documented, but not both. (See Table 4). Chi square analysis revealed there was a statistically
significant difference (p<0.001) between using the craft tool and the documentation of substance
use screening (See Table 2).
Substance use history was reviewed in the post-screening phase of the study by analyzing
the documentation of tobacco use, alcohol use, and drug use. The post-screening phase of the
study history of substance abuse was documented as followed: smoking-90.6%, alcohol-62.1%,
and drug use-62.5% (See Table 3). There was a downward trend in the documenting of alcohol
and drug use from the pre-screening to the post-screening phases of the study and it is unclear
why this occurred. The Fishers Exact test revealed no association between documenting
substance use history and screening for substance abuse.
Discussion
This study was able to achieve the goal of assessing the frequency of documentation for
substance use screening, counseling, and/or intervention in a pediatric clinic before and after the
implementation of the CRAFFT tool. Although there was an increase in screening from 10%
before the CRAFFT was implemented, to 30% after implementation, only 10% utilized the
CRAFFT Tool in the post implementation phase; the other 20% of screening was documented by
providers in the chart narrative as the patients had no “risk factors”. Continued research is
needed to understand the under utilization of the CRAFFT tool.
According to the National Institute on Drug Abuse (2003) and Lambe & Craig (2017),
risk factors for substance use include but are not limited to the following: lack of parental
attachment, ineffective parenting, caregiver is a drug abuser, emotional maltreatment, physical
maltreatment of any kind, divorce, or single family homes; attention problems (ADHD, ADD),
depression, eating disorders; poor class attention, academic failure, peers using drugs, and
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bullying; Juvenile system involvement; and transitions such as middle school to high school,
college, or a new work environment (NIDA, 2003; Lambe & Craig, 2017). These are the risk
factors identified throughout research on adolescent substance use, it is unclear which of the risk
factors were asked of the patients in this study when ‘no risk factors’ was documented.
Continued research efforts to identify the providers definition of risk factors may be completed
in the future.
Documentation of substance use history was relatively high for each phase of the study,
however a decrease of alcohol and drug history documentation was identified from the preCRAFFT screening phase of the study to the post-CRAFFT screening phase of the study.
Although, there was no correlation between the documentation of substance use history and
substance use screening this is noted as clinically significant as all patients should have 100% of
substance use history documented. Further research is needed to understand why there is not a
100% documentation rate.
Practice Implications
Moving forward with the effort toward improving adolescent substance use, screening is
still needed. To counteract the narrative note saying ‘no risk factors’, the creation of a list of
substance use risk factors for providers to review when screening adolescents for substance use
would maintain consistency and standardization. Consistency and standardization are important
as it helps maintain best practice, creates low variability, improves quality of care, improves
productivity, and increases patient safety (Shaywitz, 2009). Evidence based risk factors include
family structure, academic behavior and grades, peers using drugs, transitioning from middle
school to high school, current or history of physical maltreatment, emotional maltreatment,
sexual abuse, divorced family units, household member a current or recovering alcohol or drug
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abuser, attention problems (ADHD, ADD), history of depression, history of eating disorder, and
being bullied or bulling (NIDA, 2003). The problem of insufficient or vague documentation of
the presence or absence of risk factors could be addressed by creating a template with standard
yes/no responses to each risk factor. This could help maintain the consistency and
standardization of screening for the same risk factors attributed to increased adolescent substance
use.
Creating standardized evidence based educational sessions on substance use screening
may greatly increase the number of adolescents screened, especially as the office staff becomes
more aware of the current drug epidemic and the recommended guidelines from the American
Academy of Pediatrics on substance use screening. The American Academy of Pediatrics
recommends the routine use of the CRAFFT tool, as the DSM-5 criteria reports its good
sensitivity and specificity (Mitchell et al, 2014). Evidence such as, an adolescent is sixty-five
times more likely to use marijuana if they smoke cigarettes or drink alcohol can be detected
through substance use screening which is why substance use screening is so important within the
adolescent population. This is especially true in Kentucky since it is the third highest in the
nation for smoking among high school students (Cole, Logan & Scrivner, 2017; American
Academy of Pediatrics, 2010). Education on when to begin screening (twelve years of age) is
one of the most important aspects of screening due to adolescents experimenting with tobacco,
alcohol or drugs earlier in life, putting them at a greater risk for serious health problems
(American Academy of Pediatrics, 2010).
Time efficiency is an important factor when educating staff on a practice change and
adding to an already busy schedule. The CRAFFT screening tool is one-page document that
when used correctly captures substance use and risks for substance use in adolescents. In 2016,

14

Adolescent Substance Use Screening
Harris et al, conducted a research study to compare the time it took for the CRAFFT tool to be
completed by either self-administration or clinician administration on a tablet (Harris et al,
2015). This study reported the average time it took when the CRAFFT tool was selfadministered was 49 seconds, and when a clinician administered it took an average of 74 seconds
(Harris et al, 2015). Educating staff on the importance of screening adolescents for substance
use with an evidence-based screening tool may improve screening and sustain the use of the
CRAFFT at a minimum of once a year during annual physical exam, as well as, aid in the
reduction of the current drug epidemic.
Another clinical implication of this study would be to implement a health maintenance
pop-up tab in the electronic medical record for annual substance use screening. This would
create a visual reminder to screen adolescents at a minimum of once a year. There are current
health maintenance pop-ups for vaccines, depression screening and cholesterol screening that are
acknowledged by the MA and the provider, and the input of date is required when the health
maintenance is completed. A substance use screening pop-up could be an added visual reminder
to screen adolescents during annual well visits.
Research Implications
Ongoing research is needed to improve the continued use of the CRAFFT tool as well as
adolescent substance use screening overall. Although this study revealed an increase in
substance use screening after the practice site implemented the CRAFFT tool, only 30% of
patients were being screened. Future research is needed to understand barriers to screening.
Future implementation of a quality improvement (QI) project focused on screening adolescents
for substance use including focus groups for medical assistants and providers may provide some
answers and ultimately improve substance use screening. After the implementation of the
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evidence based CRAFFT tool regular meetings between the medical assistance and providers
could help identify areas of needed improvement to capture every adolescent. A DNP prepared
nurse is prepared to implement such a project and evaluate the continued growth of the practice
change. The implementation of the QI project could create a standardized adolescent substance
abuse screening method, process and documentation within the organization. The overall
benefits of the project implementation could be to create a standard practice change of substance
abuse screening for adolescents 12 to 17 years of age to be implemented throughout the whole
healthcare organization. Moving forward it is imperative to identify reasons the CRAFFT Tool
was not utilized. Implementing a practice change creates a work flow change and needs
adjustment time, however understanding methods that aid in increasing adolescent screening is
imperative. Evaluating medical assistant and provider compliance is important to understanding
why screening is not being conducted. Identifying reasons for missed opportunities is key to
improving screening and improving best practice. This could be done by reaching out to medical
assistants and providers via questionnaires.
Future research for screening for adolescent substance abuse is key in maintaining
consistency for practice change. Evaluating the continued use of the CRAFFT Tool at
incremental time points such as at the six-month, one year, and two-year time points would help
identify the sustainability of the practice change. Monitoring adolescent substance use screening
is an essential part of the pediatric evaluation according to the American Academy of Child and
Adolescent Psychiatry and the Academy of Pediatrics (Oesterle, Hitschfeld, Lineberry, &
Schneekloth, 2015).
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Limitations
Various limitations were identified throughout the study. The principal investigator (PI)
made an initial visit distributing educational material as well as face to face education.
Additional visits to the clinic to provide education may have increased the awareness of the
practice change of implementing the CRAFFT tool by the clinic. Although the PI made clinic
visits once a month to follow up with education and ensure the office had PI contact information,
additional visits may have provided the opportunity for more education or clarification. This
may have ultimately increased the use of the CRAFFT Tool and overall substance use screening.
If an MA or provider was off the day of face to face education, the PI left extra
educational packets in the office to be passed out to the MAs who were not in the office.
Educational packets for the providers who were not in the office were left on their desk. It is
uncertain if the extra educational packets where given to the MAs who did not personally receive
one, or if the providers reviewed the educational packet left on their desk. Additional
educational visits could have had an impact on the improvement of screening adolescents for
substance abuse as well as using the CRAFFT Tool.
Another limitation to the study was the unknown consistency with which the office staff
provided adolescents the CRAFFT Tool for substance use screening. There are multiple MAs
within the office as well as MAs that float to the office to provide coverage when needed.
Standard consistency in providing the CRAFFT Tool and scanning the tool into the patient’s
chart may have varied. This also created a limitation regarding how the CRAFFT Tool was
delivered to the adolescent. It is recommended the CRAFFT Tool to be administered without
parents/guardians in the room as this can create under reporting of substance use and risks (The
Center for Adolescent Substance Abuse Research, 2016). The CRAFFT Tool was also to be
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scanned into the patient’s chart, it is uncertain if this was occurring on a regular basis as in the
post-screening chart review there were only ten charts out of one hundred with the CRAFFT
scanned into the medical record. Implementing a standardized administration of the CRAFFT
tool as well as documentation will reduce missed opportunities of capturing adolescents for
screening.
Conclusion
The purpose of this research study was to assess a method to improve adolescent
substance abuse screening within a pediatric setting. The pediatric office implemented the
evidence-based CRAFFT Tool to screen adolescents for substance use and the practice
improvement project was used to evaluate impact on screening rates. Data analysis identified
adolescent substance use screening was documented 10% of the time before the tool was
implemented and increased to 30% after implementing the CRAFFT Tool. Substance use
screening was found to be documented either by risk factors or the CRAFFT score, with risk
factors being documented at a higher rate. Although screening improved in the post-screening
phase of the study, there was still only a 30% screening rate multiple there is still much more
room for improvement. Evidence based strategies that may improve screening were suggested:
1) Education about screening recommendations and utilizing the CRAFFT tool; 2) Check list for
risk factors; 3) Creation of a health maintenance pop up tab. Future research and suggested
practice implications may aid in the continued improvement of adolescent substance use
screening.
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Tables
Table 1. Demographic characteristics
Pre-CRAFFT tool
(n =96)

Post-CRAFFT tool
(n =96)

Mean (SD) or n (%)

Mean (SD) or n (%)

15

14

56 (58.3%)
40 (41.7%)

38 (39.6%)
58 (60.4%)

89 (92.7%)
5 (5.2%)
1 (1.04%)
1 (1.04%)
0

89 (92.7%)
3 (3.1%)
0
2 (2.01%)
1 (1.04%)

Age
Gender
Male
Female
Race
Caucasian
African American
Indian
Hispanic
Asian

Table 2: Descriptive summary of Documented Substance Use Screening

Documented
Substance Use
Screening

Pre-screening
(n=96)

Post-screening
(n=96)

n(%)

n(%)

10 (10.4%)

30 (31%)
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p-value

.001
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Table 3: Descriptive summary of Substance Use History Documentation

Smoking history documented
Yes
No
Alcohol Use
Yes
No
Drug Use
Yes
No
CRAFT tool documented
Yes
No

Pre-CRAFT tool
(n = 96)

Post-CRAFT tool
(n = 96)

n (%)

n (%)

86.5
13.5

90.6
9.4

69.8
30.2

62.1
37.9

70.8
29.2

62.5
37.5
10.4

Table 4: Descriptive Summary of Number of Adolescents Screened/Number of Adolescents
Given Anticipatory Guidance
Sample

Pre-screening
Post screening

n=96
n=96

Screened

10 (9.6%)
29 (31%)
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Anticipatory
Guidance

10 (9.6%)
16 (17%)

Both
(Screened
and
anticipatory
guidance
1 (10%)
9 (30%)
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